Considerations for Treating Patients With Chronic Total Occlusion of Coronary Arteries - 05/09/19
Doi : 10.1016/j.hlc.2019.08.003
James J.H. Chong, MBBS, PhD, FRACP a, b, c, ⁎ 
, Sujitha Thavapalachandran, MBBS, FRACP a, b, c, Andrew T.L. Ong, MBBS, PhD, FRACP b, c
, Sujitha Thavapalachandran, MBBS, FRACP a, b, c, Andrew T.L. Ong, MBBS, PhD, FRACP b, c a Centre for Heart Research, Westmead Institute for Medical Research, Sydney, NSW, Australia
b Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia
c Sydney Medical School, University of Sydney, Sydney, NSW, Australia
⁎Corresponding author at: Department of Cardiology, Westmead Hospital, Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, Sydney, NSW, 2145, Australia. Tel. 61-2-98456795, fax: 61-2-94755155.Department of CardiologyWestmead HospitalWestmead Institute for Medical Research176 Hawkesbury RoadWestmeadSydneyNSW2145Australia
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2019
Pubblicato da Elsevier Masson SAS.
Vol 28 - N° 10
P. 1452-1453 - ottobre 2019 Ritorno al numero
Articolo precedente
- Tackling Disparities in Heart Care and Disease Outcomes in Women: Insights and Highlights From the Women and Heart Disease Forum
- Clare Arnott, William A. Parsonage, Gemma A. Figtree
- Anthracycline-Induced Cardiotoxicity: Time to Focus on Cardioprotection Again
- A.J. Croft, D.T.M. Ngo, A.L. Sverdlov
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?